SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Varian Semiconductor Equipment Associates -- VSEA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Duker who wrote (39)5/17/1999 2:05:00 PM
From: Duker  Read Replies (2) of 1929
 
Here are my notes from the call:

Sorry if they are sloppy ... I think I captured the information correctly, but I urge you to listen to the call yourselves @ Replay: 619-812-6440 #12345350.

-- Gross Margin came in at 7.1% versus 35.7% y/y.

-- The GM would have been 25% w/o the charges.

-- The charges broke down this way: $11.6mm restructuring/one time and $5mm warranty and reserves ("balance sheet strengthening" ... saving a few dollars for a rainy day?).

Attribution:
5.9mm Cost of Goods
1.6mm R&D
1.5mm G&A
2.6mm Special Line Item
_____

$11.6mm ($.26/Share)

Also:
$5.0mm Inventory Reserves et. al. ($.11/Share)

So, Total Special Charges Accounted for $.37/Share of the Loss.

--Revenues were ~50% Product and ~50% Service (Wow!)

--High Energy Implant (acq. from Genus) is doing quite well. It is capturing a 40% market share in terms of new orders (up from 19% when it was acquired a few months ago)

--SG&A would have been down if you excluded the special charge.

--Over the next couple of quarters this line item will be up $1.0 to $1.5mm ... as a result of some systems work ... SAP strikes again!!!

--The core SG&A run-rate is about $7mm per quarter (w/o a ton of seasonality ... except for the SAP work in the next one to two quarters).

--Tax rate was 31.7% (expect it to be in the 30-35% range in the coming quarters ... further refinement TBA).

--DSOs were at 91 days and INVx's were at 3x's.

--Operating cash used during the quarter was $8mm and CapEx ran $2mm.

--On the market for Ion Implanters: He quoted Dataquest numbers that project the market to grow at a 34% rate over the next several years (albeit from a very deep trough).

--The Vista Single-Wafer Platform was lauded by Aurelio for its low CoO ... its indifference to 200mm or 300mm ... its ability to perform High-Tilt Implants ... its throughput (potential to reduce cycle time) ... its flexibility for "specials" without dummies ... and its overall goodness!

--Aurelio also stressed the importance of having the full suite of products High Engergy/High Current/Mid Current because it allows the customer to really reduce training costs and parts/service costs ...

--Aurelio stressed that the market was returning ... driven, for them, by Taiwan.

--Bookings were in the range of 1.2 to 1.7 ( a bigger than a breadbox ... smaller than an implanter answer!)

--Bookings mix was 2/3 Memory and 1/3 Logic ... expect that this will return to 50/50 with the help of Taiwan's logic buys.

--Expect to see a sequential increase in bookings (N.B., This is a change from the previous guidance of "we do not have the visibility to see...")

--Backlog sits at about 2Q (on what revenue assumptions, I do not know).

--Lead times are b/w 3-6 months depending on the product.

--Company has signed up some new customers ... outside the Memory area for the Genus High Energy product.

--Aurelio on the competition: "... clear that we are gaining share." Still, very tough competition ... ETN & AMAT ...

--High Energy is 10-20% of revenues.

--Aurelio really stressed the Suite of Products: important from a customer standpoint with like Robotics/Software/GUI/...

--Breakeven is about $70-75mm ...

--Anticipate profitability at FY00 1Q.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext